Latest News

CHAIN joins University of Nottingham Synthetic Biology Research Centre

CHAIN Biotechnology Ltd is proud to announce a new collaboration with Professor Nigel Minton’s Clostridial Research Group at the University of Nottingham’s recently-established £14.3 million Synthetic Biology Research Centre (SBRC). Two strain development scientists will begin working full-time within the SBRC alongside world leaders in the field of Clostridial research. The CHAIN team will utilise cutting-edge synthetic biology and metabolic engineering tools developed in the centre for creating industrially robust microbial hosts or “chassis” for the production of high-value fine chemicals.

Dr Edward Green comments “We are excited to work with the SBRC led by Professor Nigel Minton and get the opportunity to access world class science, research expertise and capability. The integration of a company within an academic research centre is a new way to work and one that should accelerate the commercialisation of research outputs.”

Dr Alan Burbidge, Centre Manager SBRC-Nottingham added: “These are exciting times for synthetic biology and having a close relationship with CHAIN gives us the opportunity to build closer links between academia and industry to exchange knowledge and to translate new techniques and materials in microbial synthetic biology to the industrial base for real-world applications.”

Related News

CHAIN Appoints New Board Members

CHAIN welcomes to its Board of Directors the recent appointment of Dr Mike McDonald...

CHAIN Finalists in Biotechnology Awards

CHAIN Biotechnology is proud to announce that it is a finalist in two competitions...

CHAIN Celebrates Successful ‘Chiral Chemical Synthesis in Clostridia’ Study

LONDON, UK, 10 AUGUST 2016 -- CHAIN Biotechnology Ltd has successfully completed a 12-month...

omega 3 nutritional supplements
CHAIN Obtains Grant Funding For Collaborative Projects

June 11, 2016 – London, UK. CHAIN Biotechnology Ltd has won grant funding for...

CHAIN new employees clostridium modular vectors omega 3
CHAIN Welcomes New Starters

CHAIN has hired two new world class scientific team members to expand its role...

CHAIN Secures Seed Funding and Appoints New Board Members

London, UK, 23 December, 2015 CHAIN has successfully completed its first round of seed funding...

CHAIN HPLC Analysis of Chiral Chemicals Innovate UK feasibility study for Collaboration Nation: synthetic biology and strain development of anaerobic bacteria
CHAIN Celebrates Feasibility Study Success at Collaboration Nation

CHAIN Biotech has successfully completed a feasibility study into altering bacterial metabolism to produce...

CHAIN Wins Business Interaction Voucher for clostridia strain development
CHAIN Wins Business Interaction Voucher with University of Nottingham

CHAIN Biotechnology has been awarded a £5,000 Business Interaction Voucher in partnership with the...

CHAIN launches a new grant funded research project

CHAIN has been awarded £180K from InnovateUK for a project focused on the production...

CHAIN wins award and launches new website

Award winning CHAIN Biotech launches its new website, funded by a prize voucher from...

CHAIN hires Research Manager

CHAIN Biotechnology Ltd welcomes Dr Dana Heldt. Dana is an experienced strain development scientist...